3-Oxoandrosta-1,4-dien-17-yl acetate(CAS: 2363-59-9)

3-Oxoandrosta-1,4-dien-17-yl acetate (CAS: 2363-59-9) should comply with the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), REACH regulations for European markets, and FDA/EPA requirements for pharmaceutical and agricultural applications. Specific handling and disposal guidelines must also adhere to local and national environmental and safety standards.

Several alternatives can be used in the synthesis of 3-Oxoandrosta-1,4-dien-17-yl acetate (CAS: 2363-59-9), including 17-hydroxyandrost-1,4-diene-3-one and other similar compounds. Common alternative reagents such as acetophenone or acetates can also be considered based on the specific reaction conditions.

The market for 3-Oxoandrosta-1,4-dien-17-yl acetate (CAS: 2363-59-9) is driven by its use in pharmaceuticals and cosmetics. Research trends are focusing on its potential in hormone therapy and as a skin care ingredient. Emerging studies are exploring its synthetic intermediacy in steroid chemistry.

Waste containing 3-Oxoandrosta-1,4-dien-17-yl acetate (CAS: 2363-59-9) should be collected and disposed of in accordance with local regulations. This may involve neutralization to neutral pH, incineration, or professional waste disposal services that comply with environmental protection standards. Proper personal protective equipment should be worn during handling to avoid exposure.